Volume 12, Number 7—July 2006
Research
Neisseria meningitidis Sequence Type and Risk for Death, Iceland
Magnús Gottfreðsson*†
, Mathew A. Diggle‡, David I. Lawrie‡, Helga Erlendsdóttir*, Hjördís Harðardóttir*, Karl G. Kristinsson*†, and Stuart C. Clarke‡§
, Mathew A. Diggle‡, David I. Lawrie‡, Helga Erlendsdóttir*, Hjördís Harðardóttir*, Karl G. Kristinsson*†, and Stuart C. Clarke‡§
Table 1
Description of the patient cohort
| Parameter | No. (%) |
|---|---|
| Patients | 362 |
| Male | 185 (51.1) |
| Female | 177 (48.9) |
| Children* | 244 (67.4) |
| Adults | 118 (32.6) |
| Strain isolated from cerebrospinal fluid only | 144 (39.8) |
| Strain isolated from blood only | 105 (29.0) |
| Strain isolated from cerebrospinal fluid and blood | 78 (21.5) |
| Strain isolated from joint fluid | 10 (2.8) |
| Strain grown from throat culture† | 25 (6.9) |
| Serogroup A | 8 (2.2) |
| Serogroup B | 204 (56.4) |
| Serogroup C | 144 (39.8) |
| Serogroup Y | 3 (0.8) |
| Serogroup W135 | 3 (0.8) |
*<16 years of age at the time of diagnosis.
†Positive throat culture in the setting of invasive meningococcal disease, diagnosed clinically.
Page created: December 19, 2011
Page updated: December 19, 2011
Page reviewed: December 19, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.